| Mantis, Nicholas J. |
Wadsworth Center
United States |
High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology |
3U01CA260508-02S1 |
| Smith, Ellen Mary Lavoie |
University Of Alabama At Birmingham
United States |
Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study |
5R01CA235726-07 |
| Hunter, Jessica Ezzell |
Kaiser Foundation Research Institute
United States |
Leveraging tumor registries and pathology specimens to facilitate genetic testing and traceback for ovarian cancer |
5U01CA244323-04 |
| Shen, Qiang |
Lsu Health Sciences Center
United States |
Chemoprevention of Breast Cancer by Targeting Glucose Metabolism with HJC0152 |
5R01CA226001-06 |
| Pitteri, Sharon |
Stanford University
United States |
Glycosylation and Immune Evasion in Urologic Tumors |
5U01CA226051-05 |
| Taouli, Bachir |
Icahn School Of Medicine At Mount Sinai
United States |
Abbreviated MRI for HCC screening in cirrhotic patients |
5R01CA249765-04 |
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |